14 September 2022 | BST (UTC+1)
An intensive 1-day meeting that delves into the latest in oligonucleotides chemistry, process & analytical development, therapeutics, antisense therapy & a meeting place for experts working within cutting-edge oligo research & therapeutic development.
Our Symposiums are delivered through Swapcard, our market-leading and highly interactive digital event platform. Alongside the live programme, it has a variety of other features to maximise your event experience, including AI-assisted match-making with other delegates, additional resource such as white papers, exhibitor pages allowing you to connect with leading solution providers and a host of On-Demand content.
Our LinkedIn group aims to foster discussion and collaboration between experts working in proteins, bispecifics, peptides and oligonucleotides
Attendees representing global pharmaceutical organisations, leading biotech companies and internationally renowned academic institutions working within Oligonucleotides
Track 1 – Oligo Chemistry, Formulation & Delivery AI/Machine Learning
Track 2 – Oligo Therapeutics
The Symposium brings together a panel of prominent leaders, engineers and scientists sharing new case studies, innovative data and industry outlook for the future
Below were some of the key speakers of our Virtual Symposium: Oligonucleotides: Chemistry & Therapeutics 2021 Event
Wave Life Sciences
Ionis Pharmaceuticals
AstraZeneca
AstraZeneca
Networking and knowledge-sharing is at the heart of what we do. Alongside the innovative programme, attendees can engage in a variety of event features and make the most of participation in a range of virtual, remote experiences.
We produce cutting edge congresses and summits for the Life Sciences Industry, bringing together industry leaders and solution providers at a senior level, creating the opportunity to partner, network and knowledge share.
For over sixty years, Waters Corporation has developed innovative analytical science solutions to support customer discoveries, operations, performance, and regulatory compliance.
Waters Corporation, holds worldwide leading positions in complementary analytical technologies – liquid chromatography, mass spectrometry, rheometry, and microcalorimetry.
Specifically, the company designs, manufactures, sells, and services UltraPerformance Liquid Chromatography (UPLC), high performance liquid chromatography (HPLC), chromatography columns and chemistry products, mass spectrometry (MS) systems, thermal analysis, and rheometry instruments
Waters Division creates business advantages for laboratory-dependent organizations by delivering practical and sustainable scientific innovation to enable significant advancement in healthcare delivery, environmental management, food safety, and water quality. Waters Division products are used by pharmaceutical, life science, biochemical, industrial, academic, and government organizations working in research and development, quality assurance, and other laboratory applications. Waters UPLC, HPLC, and MS instruments and consumables are used in a broad range of industries to measure the chemical, physical, and biological composition of materials.
ST Pharm is a subsidiary company of Dong-A Socio Group, Korea’s top pharmaceutical company with a history of 80 years. ST Pharm operates fully integrated services, including CRO and CDMO business, which allows one-stop service from pre-clinical stage to commercialisation. The main business of ST Pharm is API CDMO business and producing now more than 40 pipelines of excellent quality APIs through our ample knowledge and accumulated know-hows. The expansion of production capabilities in the production of oligonucleotides became a new growth engine for the future. In particular, the establishment of Oligonucleotide Plant in 2018 has secured our place in the Global Top 3 oligonucleotide production company. In 2020, ST Pharm has launched new manufacturing business for mRNA vaccines and therapeutics and the decision has been made to compete for preoccupancy of rapidly growing global mRNA vaccine markets.
Bio-Works is the home of WorkBeads™, innovative and advanced agarose-based chromatography resins. We supply resins for purification of a broad range of biomolecules in research, process development or at manufacturing scale and our products are used in academic research laboratories, biopharmaceutical companies and many more areas. WorkBeads resins are manufactured using a proprietary method that results in outstanding purity, high binding capacity and high flow rates.
Bio-Works’ site for R&D, manufacturing and supply is located in Fyrislund, Uppsala, a place strongly associated with chromatography. Our staff have a wealth and depth of experience in developing and using resins for separation and purification, allowing us to innovate for the best of the industry. We provide customers with tailored solutions and put their needs at the heart of what we do.